BETA-N-ACETYL-D-GLUCOSAMINIDASE INCREASED side effect
What is BETA-N-ACETYL-D-GLUCOSAMINIDASE INCREASED ?BETA-N-ACETYL-D-GLUCOSAMINIDASE INCREASED : Tacrolimus Side Effects Report #5622133-4
Physician from JAPAN reported TACROLIMUS problem on Jan 22, 2008. Female patient, 66 years of age, weighting 108.0 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: beta-n-acetyl-d-glucosaminidase increased, condition aggravated, hepatitis b, hepatorenal syndrome, lymphocyte count decreased, . TACROLIMUS dosage: 1.5 MG, UID/QD, ORAL; 3 MG, UID/QD, ORAL. During the same period patient was treated with PREDNISOLONE, METHOTREXATE, ENBREL, ETODOLAC, VOLTAREN, ISCOTIN. Patient died on 05/03/2007.
BETA-N-ACETYL-D-GLUCOSAMINIDASE INCREASED : Tacrolimus Side Effects Report #5584784-5
TACROLIMUS problem was reported by a Physician from JAPAN on Dec 25, 2007. Female patient, 66 years of age, weighting 108.0 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: beta-n-acetyl-d-glucosaminidase increased, condition aggravated, hepatitis b, hepatorenal syndrome, lymphocyte count decreased, . TACROLIMUS dosage: 1.5 MG, UID/QD; ORAL, 3MG, UID/QD; ORAL,. During the same period patient was treated with PREDNISOLONE, METHOTREXATE, ENBREL, ETODOLAC, VOLTAREN, ISCOTIN. Patient died on 05/03/2007.
BETA-N-ACETYL-D-GLUCOSAMINIDASE INCREASED : Tacrolimus Side Effects Report #5574136-6
Physician from JAPAN reported TACROLIMUS problem on Dec 05, 2007. Female patient, 66 years of age, weighting 108.0 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: beta-n-acetyl-d-glucosaminidase increased, hepatorenal syndrome, lymphocyte count decreased, . TACROLIMUS dosage: 1.5 MG/D, ORAL; 3 MG, ORAL. During the same period patient was treated with PREDNISOLONE, METHOTREXATE, ENBREL, HYPEN, VOLTAREN, ISCOTIN. Patient died on 05/03/2007.
BETA-N-ACETYL-D-GLUCOSAMINIDASE INCREASED : Tacrolimus Side Effects Report #5503565-1
TACROLIMUS problem was reported by a Physician from JAPAN on Oct 16, 2007. Female patient, 75 years of age, weighting 103.6 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: beta-n-acetyl-d-glucosaminidase increased, blood creatinine increased, dehydration, glycosylated haemoglobin increased, interstitial lung disease, pneumonia bacterial, pneumonia chlamydial, upper limb fracture, . TACROLIMUS dosage: 1.5 MG, UID/QD, ORAL; 1 MG, UID/QD, ORAL. During the same period patient was treated with PREDNISONE, ETODOLAC, AZULFIDINE EN, PROTECADIN, MUCOSTA. Patient was hospitalized. Patient died on 09/03/2007.
BETA-N-ACETYL-D-GLUCOSAMINIDASE INCREASED : Velcade Side Effects Report #5468625-2
Physician from MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF reported VELCADE problem on Sept 14, 2007. Male patient, 62 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: beta-n-acetyl-d-glucosaminidase increased, dialysis, gamma-glutamyltransferase increased, hyperkalaemia, hypocalcaemia, hypophosphataemia, prostration, renal failure acute, . VELCADE dosage: 1.30 MG/M2,. During the same period patient was treated with CORTICOSTEROIDS. Patient was hospitalized. Patient died.
BETA-N-ACETYL-D-GLUCOSAMINIDASE INCREASED : Diovan Side Effects Report #5469134-7
DIOVAN problem was reported by a Physician from JAPAN on Sept 20, 2007. Male patient was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: beta-n-acetyl-d-glucosaminidase increased, haematuria, occult blood positive, protein urine present, . DIOVAN dosage: 80 MG, QD. During the same period patient was treated with NORVASC. Patient recovered.
BETA-N-ACETYL-D-GLUCOSAMINIDASE INCREASED : Klaricid Side Effects Report #5664808-7
Physician from JAPAN reported KLARICID problem on Mar 10, 2008. Male patient, weighting 126.8 lb, was diagnosed with chronic sinusitis, hypogammaglobulinaemia and was treated with KLARICID. After drug was administered, patient experienced the following problems/side effects: beta 2 microglobulin increased, beta-n-acetyl-d-glucosaminidase increased, hypoalbuminaemia, hypoproteinaemia, renal tubular disorder, sensation of heaviness, . KLARICID dosage: unknown. During the same period patient was treated with AMBROXOL HYDROCHLORIDE, PRONASE, THEOPHYLLINE, IMMUNE GLOBULIN, SULTAMICILLIN TOSILATE, PIPERACILLIN AND TAZOBACTAM. Patient was hospitalized. Patient recovered.
BETA-N-ACETYL-D-GLUCOSAMINIDASE INCREASED : Tacrolimus Side Effects Report #5638752-5
TACROLIMUS problem was reported by a Physician from JAPAN on Dec 05, 2007. Female patient, 66 years of age, weighting 108.0 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: ammonia increased, beta-n-acetyl-d-glucosaminidase increased, condition aggravated, dyspnoea, hepatitis b, hepatorenal syndrome, lymphocyte count decreased, oedema, oedema peripheral, . TACROLIMUS dosage: 1.5 MG, UID/QD; ORAL, 3 MG, UID/QD; ORAL. During the same period patient was treated with PREDNONINE, METHOTREXATE, ENBREL, ETODOLAC, VOLTAREN, ISCOTIN. Patient died on 05/03/2007.
BETA-N-ACETYL-D-GLUCOSAMINIDASE INCREASED : Klaricid Side Effects Report #5643755-0
Physician from JAPAN reported KLARICID problem on Feb 20, 2008. Male patient, weighting 126.8 lb, was diagnosed with chronic sinusitis, hypogammaglobulinaemia and was treated with KLARICID. After drug was administered, patient experienced the following problems/side effects: beta 2 microglobulin increased, beta-n-acetyl-d-glucosaminidase increased, hypoalbuminaemia, hypoproteinaemia, renal tubular disorder, sensation of heaviness, . KLARICID dosage: unknown. During the same period patient was treated with AMBROXOL HYDROCHLORIDE, PRONASE, THEOPHYLLINE, IMMUNE GLOBULIN, SULTAMICILLIN TOSILATE, PIPERACILLIN AND TAZOBACTAM. Patient was hospitalized. Patient recovered.